Gangnam Severance Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1983-04-01

Employees: -

Market Cap: -

Website: https://gs.severance.healthcare

Clinical Trials

Comparison of IONM Between Remimazolam and Propofol

Not Applicable

Completed

Conditions: Ossification Posterior Longitudinal Ligament
Cervical Spondylotic Myelopathy

Interventions: Drug: Arm II (Remimazolam)
Drug: Arm I (Propofol)

First Posted Date: 2021-07-20

Last Posted Date: 2023-10-18

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 66

Registration Number: NCT04968054

Locations: 🇰🇷
GangnamSeverance Hospital, Seoul, Korea, Republic of

Non-thermal Plasma for Sebum Reduction in Oily Facial Skin

Not Applicable

Completed

Conditions: Oily Skin

Interventions: Device: PLADUO(PX1000)

First Posted Date: 2021-06-08

Last Posted Date: 2021-06-08

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 14

Registration Number: NCT04917835

Locations: 🇰🇷
GangnamSeverance Hospital, Seoul, Korea, Republic of

Remimazolam Bolus for General Anesthesia

Phase 3

Completed

Conditions: Loss of Consciousness

Interventions: Drug: 0.02 mg/kg, age<65
Drug: 0.17 mg/kg, age<65
Drug: 0.07 mg/kg, age≥65
Drug: 0.27 mg/kg, age<65
Drug: 0.07 mg/kg, age<65
Drug: 0.12 mg/kg, age≥65
Drug: 0.12 mg/kg, age<65
Drug: 0.27 mg/kg, age≥65
Drug: 0.22 mg/kg, age<65
Drug: 0.02 mg/kg, age≥65
Drug: 0.17 mg/kg, age≥65
Drug: 0.22 mg/kg, age≥65

First Posted Date: 2021-05-26

Last Posted Date: 2021-07-28

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 120

Registration Number: NCT04901871

Locations: 🇰🇷
Gangnam Severance Hospital, Seoul, Korea, Republic of

Acetaminophen and AKI After Aortic Surgery

Not Applicable

Recruiting

Conditions: Aortic Surgery

Interventions: Other: Placebo
Drug: Acetaminophen

First Posted Date: 2021-05-11

Last Posted Date: 2024-02-07

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 136

Registration Number: NCT04882202

Locations: 🇰🇷
Gangnam Severance Hospital, Seoul, Korea, Republic of

Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)

Phase 2

Recruiting

Conditions: HER2 Enriched Subtype Breast Cancer, Herzuma, PAM50 Study

Interventions: Drug: Herzuma

First Posted Date: 2021-03-26

Last Posted Date: 2023-10-11

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 59

Registration Number: NCT04817540

Locations: 🇰🇷
Gangnam Severance Hospital, Seoul, Korea, Republic of

A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination

Phase 2

Conditions: Advanced Gastric Cancer
Peritoneal Carcinomatosis

Interventions: Procedure: 2. Response evaluation after 4 cycles of IP + systemic chemotherapy

First Posted Date: 2021-03-15

Last Posted Date: 2021-03-15

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 43

Registration Number: NCT04797923

Locations: 🇰🇷
Gangnam Severacne Hospital, Seoul, Gangnnam, Korea, Republic of

Multimodal Analgesia for Cholecystectomy

Phase 3

Completed

Conditions: Laparoscopic Cholecystectomy

Interventions: Drug: Celebrex, acetaminophen, and dexamethasone
Procedure: Saline irrigation, aspiration of pneumoperitoneum, and low pressure penumoperitoneum

First Posted Date: 2021-03-09

Last Posted Date: 2023-10-06

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 60

Registration Number: NCT04788654

Locations: 🇰🇷
Do-Hyeong Kim, Seoul, Korea, Republic of

MEP and Neuromuscular Blocker

Not Applicable

Completed

Conditions: Brain Tumor

Interventions: Drug: Arm I (MEP)

First Posted Date: 2021-02-24

Last Posted Date: 2023-06-06

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 100

Registration Number: NCT04768400

Locations: 🇰🇷
GangnamSeverance Hospital, Seoul, Korea, Republic of

Clinical Validation of an Immunocytochemistry Method Using MARS1

Not Applicable

Conditions: Bile Duct Obstruction, Extrahepatic

Interventions: Diagnostic Test: Cytology staining

First Posted Date: 2021-02-18

Last Posted Date: 2022-08-03

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 200

Registration Number: NCT04759794

Locations: 🇰🇷
Gangnam Severance Hospital, Seoul, Gangnam-gu, Korea, Republic of
🇰🇷
CHA Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of
🇰🇷
In Ha University Hospital, Incheon, Jung-gu, Korea, Republic of

and more 2 locations

Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence

Not Applicable

Recruiting

Conditions: Mastectomy

Interventions: Procedure: reSLNB arm

First Posted Date: 2021-02-05

Last Posted Date: 2023-10-11

Lead Sponsor: Gangnam Severance Hospital

Target Recruit Count: 532

Registration Number: NCT04741737

Locations: 🇰🇷
Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy